Abbisko Cayman (HKSE:02256) Other Income (Expense) : HK$-1.2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abbisko Cayman Other Income (Expense)?

Abbisko Cayman's other income expense for the Abbisko Cayman's pretax income for the six months ended in Dec. 2024 was HK$2.9 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-1.2 Mil.

Abbisko Cayman Other Income (Expense) Historical Data

The historical data trend for Abbisko Cayman's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Other Income (Expense) Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-676.94

-1,851.19

-46.12

-5.48

-1.14

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial					-27.03	-14.27	8.79	-4.03	2.86

Abbisko Cayman Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.2 Mil.

Abbisko Cayman (HKSE:02256) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Abbisko Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (HKSE:02256) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

8ZD:Germany

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Executives

Xu Yao-chang	2101 Beneficial owner
Qiming Corporate Gp Vi, Ltd.	2201 Interest of corporation controlled by you
Yu Hongping	2501 Other
Chen Zhui	2501 Other
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Futu Trustee Limited	2301 Trustee
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
Yu Hongping	2501 Other
Morgan Stanley	2201 Interest of corporation controlled by you
Temasek Life Sciences Private Limited
Computershare Hong Kong Trustees Limited	2301 Trustee
Morgan Stanley Investments (uk)	2201 Interest of corporation controlled by you
Morgan Stanley International Limited	2201 Interest of corporation controlled by you

Abbisko Cayman Headlines

No Headlines